 Zika<pathogen> virus<pathogen> ( ZIKV) infection during the large epidemics in the Americas is related to congenital abnormities or fetal demise. To date , there is no vaccine , antiviral drug , or other modality available to prevent or treat Zika<pathogen> virus<pathogen> infection. Here we designed novel live attenuated ZIKV vaccine candidates using a codon pair deoptimization strategy. Three codon pair-deoptimized ZIKVs ( Min E , Min NS1 , and Min E+NS 1) were